Decreasing trends of bacteraemia among HIV-infected Ugandan adults: incidence, aetiology, clinical outcomes and effect of antiretroviral therapy in a semi-urban setting (2000-2008)

被引:10
|
作者
Muyanja, Stella Zawedde [1 ]
Larke, Natasha [2 ]
Rutebarika, Diana [3 ]
Kaddu, Ismael [3 ]
Nakubulwa, Susan [3 ]
Levin, Jonathan [3 ]
Grosskurth, Heiner [3 ]
Miiro, George [3 ]
机构
[1] Infect Dis Inst, Kampala, Uganda
[2] London Sch Hyg & Trop Med, Trop Epidemiol Grp, London, England
[3] MRC, Entebbe, Uganda
基金
英国医学研究理事会;
关键词
HIV; bacteraemia; highly active antiretroviral therapy; Uganda; HUMAN-IMMUNODEFICIENCY-VIRUS; BLOOD-STREAM INFECTIONS; STREPTOCOCCUS-PNEUMONIAE; POLYSACCHARIDE VACCINE; BACTERIAL-INFECTIONS; ERA; AFRICA; IMPACT; HAART; TRIAL;
D O I
10.1111/j.1365-3156.2011.02754.x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
P>Objective To investigate the effect of antiretroviral therapy on trends of incidence, aetiology and clinical outcomes of bacteraemia among HIV-infected Ugandans in a semi-urban setting. Methods A cohort of HIV-1-infected Ugandans aged 15 or older was followed from 2000 to 2008. Clinical, haematological and immunological measurements were taken at 6-monthly visits. Additionally, patients reported to outpatient clinics whenever they were ill. Patients with elevated axillary temperature above 37.4 degrees C consistently triggered clinical assessment (with mandatory blood cultures) and empirical management protocol. Daily cotrimoxazole prophylaxis and highly active antiretroviral therapy (HAART) were introduced stepwise to eligible patients in August 2000 and February 2003, respectively. We compared the rates of bacteraemia across five calendar periods using random-effects Poisson regression for the effect of HAART at the population level. Results A total of 246 bacteraemia episodes (including multiple episodes) were documented among 188 individuals (crude incidence: 42.4 events per 1000 person-years; 95% CI: 35.0, 51.4). The most common species isolated was Streptococcus pneumoniae. After adjustment for current age, clinical characteristics at enrolment (CD4+ T-cell counts and WHO stage) and time since enrolment, the incidence of bacteraemia dropped significantly when HAART was widely available compared with the period when treatment was not available (adjusted hazard ratio: 0.17; 95% CI: 0.09, 0.35). No poor health outcomes (death or lack of clinical response to antibiotics) after bacteraemia occurred after complete access to HAART. Conclusions HAART availability in a resource-poor setting substantially reduced the trends of bacteraemia among HIV-infected adults. This may further impact on future morbidity and healthcare costs of HIV-infected people.
引用
收藏
页码:756 / 765
页数:10
相关论文
共 6 条
  • [1] Effect of antiretroviral therapy on malaria incidence in HIV-infected Ugandan adults
    Kasirye, Ronnie P.
    Grosskurth, Heiner
    Munderi, Paula
    Levin, Jonathan
    Anywaine, Zacchaeus
    Nunn, Andrew
    Kamali, Anatoli
    Baisley, Kathy
    AIDS, 2017, 31 (04) : 577 - 582
  • [2] Sex differences in antiretroviral treatment outcomes among HIV-infected adults in an urban Tanzanian setting
    Hawkins, Claudia
    Chalamilla, Guerino
    Okuma, James
    Spiegelman, Donna
    Hertzmark, Ellen
    Aris, Eric
    Ewald, Tarcila
    Mugusi, Ferdinand
    Mtasiwa, Deo
    Fawzi, Wafaie
    AIDS, 2011, 25 (09) : 1189 - 1197
  • [3] Longitudinal effect of CD4 by cotrimoxazole use on malaria incidence among HIV-infected Ugandan adults on antiretroviral therapy: a randomized controlled study
    Ronnie Kasirye
    Heiner Grosskurth
    Paula Munderi
    Jonathan Levin
    Zacchaeus Anywaine
    Andrew Nunn
    Anatoli Kamali
    Kathy Baisley
    Malaria Journal, 15
  • [4] Longitudinal effect of CD4 by cotrimoxazole use on malaria incidence among HIV-infected Ugandan adults on antiretroviral therapy: a randomized controlled study
    Kasirye, Ronnie
    Grosskurth, Heiner
    Munderi, Paula
    Levin, Jonathan
    Anywaine, Zacchaeus
    Nunn, Andrew
    Kamali, Anatoli
    Baisley, Kathy
    MALARIA JOURNAL, 2016, 15
  • [5] US Trends in Antiretroviral Therapy Use, HIV RNA Plasma Viral Loads, and CD4 T-Lymphocyte Cell Counts Among HIV-Infected Persons, 2000 to 2008
    Althoff, Keri N.
    Buchacz, Kate
    Hall, H. Irene
    Zhang, Jinbing
    Hanna, David B.
    Rebeiro, Peter
    Gange, Stephen J.
    Moore, Richard D.
    Kitahata, Mari M.
    Gebo, Kelly A.
    Martin, Jeffrey
    Justice, Amy C.
    Horberg, Michael A.
    Hogg, Robert S.
    Sterling, Timothy R.
    Cescon, Angela
    Klein, Marina B.
    Thorne, Jennifer E.
    Crane, Heidi M.
    Mugavero, Michael J.
    Napravnik, Sonia
    Kirk, Gregory D.
    Jacobson, Lisa P.
    Brooks, John T.
    ANNALS OF INTERNAL MEDICINE, 2012, 157 (05) : 325 - U63
  • [6] AIDS and non-AIDS severe morbidity associated with hospitalizations among HIV-infected patients in two regions with universal access to care and antiretroviral therapy, France and Brazil, 2000-2008: hospital-based cohort studies
    Luz, Paula Mendes
    Bruyand, Mathias
    Ribeiro, Sayonara
    Bonnet, Fabrice
    Moreira, Ronaldo Ismerio
    Hessamfar, Mojgan
    Campos, Dayse Perreira
    Greib, Carine
    Cazanave, Charles
    Veloso, Valdilea Goncalves
    Dabis, Francois
    Grinsztejn, Beatriz
    Chene, Genevieve
    BMC INFECTIOUS DISEASES, 2014, 14